- Home
- ATRA vs IMA Comparison
ATRA vs IMA Comparison
Compare ATRA & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRA
- IMA
- Stock Information
- Founded
- ATRA 2012
- IMA 2019
- Country
- ATRA United States
- IMA United States
- Employees
- ATRA N/A
- IMA N/A
- Industry
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- IMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ATRA Health Care
- IMA Health Care
- Exchange
- ATRA Nasdaq
- IMA Nasdaq
- Market Cap
- ATRA 97.0M
- IMA 92.2M
- IPO Year
- ATRA 2014
- IMA N/A
- Fundamental
- Price
- ATRA $15.21
- IMA $8.70
- Analyst Decision
- ATRA Strong Buy
- IMA Buy
- Analyst Count
- ATRA 3
- IMA 1
- Target Price
- ATRA $21.00
- IMA $30.00
- AVG Volume (30 Days)
- ATRA 54.6K
- IMA 99.7K
- Earning Date
- ATRA 11-06-2025
- IMA 11-15-2025
- Dividend Yield
- ATRA N/A
- IMA N/A
- EPS Growth
- ATRA N/A
- IMA N/A
- EPS
- ATRA 0.56
- IMA N/A
- Revenue
- ATRA $188,667,000.00
- IMA $4,300,000.00
- Revenue This Year
- ATRA N/A
- IMA N/A
- Revenue Next Year
- ATRA N/A
- IMA N/A
- P/E Ratio
- ATRA $27.00
- IMA N/A
- Revenue Growth
- ATRA 202.41
- IMA N/A
- 52 Week Low
- ATRA $5.01
- IMA $7.24
- 52 Week High
- ATRA $18.71
- IMA $23.28
- Technical
- Relative Strength Index (RSI)
- ATRA 55.36
- IMA N/A
- Support Level
- ATRA $14.14
- IMA N/A
- Resistance Level
- ATRA $16.15
- IMA N/A
- Average True Range (ATR)
- ATRA 1.06
- IMA 0.00
- MACD
- ATRA -0.11
- IMA 0.00
- Stochastic Oscillator
- ATRA 44.28
- IMA 0.00
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
About IMA ImageneBio Inc. Common Stock
ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.